COVID-19 and Global Chronic Disease 2023

Dear Colleagues,

Coronavirus disease 2019 (COVID-19) is the condition caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since 2020, the pandemic has influenced our lives in nearly every corner of the world, causing more than 500 million cases and over 6.2 million deaths globally. The rapid spread of the disease and several waves and peaks have imposed strong pressure on the health systems worldwide. This global scenario also changes the ways to perform research. In fact, for the first time, the scholars working on COVID-19-related issues have been consulted ahead of political decisions to manage the impact of the pandemic on society and to deliver in a few months medical solutions, such as vaccines and new therapies. Furthermore, the COVID-19 crisis emphasizes the connections between research, clinical practice and health policies. However, despite these extraordinary results in human history, some points on COVID-19 need to be clarified.

Aim and Scope:

This Special Issue, titled “COVID-19 and Global Chronic Disease II”, aims to report the state of the art and the new findings on COVID-19. In particular, we want to discuss the recent novel therapies, vaccines and public health policies related to this pandemic. In this way, we invite eminent scholars and emerging researchers to submit high scientific level articles, as indicated in the keywords below.

Prof. Dr. Ludovico Abenavoli
Dr. Christian Zanza
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.